High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study

Luana FianchiIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy

Marianna CriscuoloIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy

Massimo BrecciaDipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza, Roma, Italy

Luca MaurilloIstituto di Ematologia, Fondazione Policlinico Tor Vergata, Roma, Italy

Flavia SalviEmatologia, A.O. SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Pellegrino MustoDipartimento di Onco-Hematology, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy

Giovanna MansuetoDipartimento di Onco-Hematology, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy

Gianluca GaidanoDivisione di Ematologia, Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy

Carlo FinelliS.Orsola-Malpighi University Hospital, Department of Hematology and Oncological Sciences “Seràgnoli”, Bologna, Italy

Antonietta Aloe-SpiritiDipartimento di Ematologia, Ospedale Sant’Andrea, Università La Sapienza, Roma, Italy

Valeria SantiniEmatologia, AOU Careggi, Università di Firenze, Firenze, Italy

Mariangelo GrecoDivisione di Ematologia, Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy

Stefan HohausIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy

Giuseppe LeoneIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy

Maria Teresa VosoIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, ItalyCorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Potential conflict of interest: Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study

Information for

Open access

Opportunities

Help and information

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature